瑞卢戈利在哪里买比较靠谱？

When purchasing relugolix, it is crucial to choose a reliable purchasing channel, which is related to the quality of the drug and the therapeutic effect of the patient. This article will introduce in detail the reliable purchasing channels, listing status and price of Relugoli to help patients better understand and choose.

Where to buy Relugoli more reliably

Choosing the right purchasing channel can ensure that patients get reliable quality. The following are some reliable purchasing channels.

Hospital Pharmacy

Regular pharmacies

Some qualified regular pharmacies may also sell Rilugoli. When choosing a regular pharmacy, you should check whether the pharmacy has the relevant business license to ensure that it is legal and compliant. In addition, pharmacists in regular pharmacies can provide professional medication consultation services to help patients use medications correctly.

Online formal pharmaceutical platform

With the development of the Internet, online formal pharmaceutical platforms provide patients with a convenient way to purchase medicines. Patients can choose reputable and qualified online pharmaceutical platforms to purchase Rilugoli. Before purchasing, carefully verify the qualifications and reputation of the platform and check the reviews and feedback of other patients.

The marketing status of relugoli

Understanding the marketing status of relugoli can help patients understand the accessibility and market supply of the drug.

Foreign marketing status

On January 8, 2019, Takeda’s Relugoli tablets (40 mg) were approved by Japan’s PMDA for marketing, with the trade name Relumina, for the treatment and symptom relief of uterine fibroids. On December 18, 2020, Myovant Sciences' Rilugolix tablets (120mg) were approved by the US FDA for marketing under the trade name Orgovyx for the treatment of patients with advanced prostate cancer. These listings indicate that Relugoli has gained certain recognition and application in the international market.

Domestic listing situation

Up to now, Ruilugoli has not been officially listed in China, but some companies have carried out relevant research and application work. With the development of the domestic pharmaceutical industry and policy support, Rilugoli is expected to be launched in the country to provide patients with more treatment options.

Prospects for launch

As an innovative drug, relugoli has significant advantages in the treatment of specific diseases. With the continuous deepening of clinical research and the accumulation of clinical data, its efficacy and safety will be further verified. It is expected that after Rilugoli is launched in the country, it will attract the attention and demand of a large number of patients, and the market prospects are broad.

The price of relugolix

The price of relugolix is ​​affected by many factors. Understanding its price situation can help patients make financial preparations.

Foreign price situation

Take Rilugoli produced by Japan's Takeda as an example. The specification is 40mg*100 capsules/box, and the reference price is about US$152. Due to the lack of generic drugs, original drugs have become the only option and are relatively expensive. There may be certain differences in prices in different countries and regions, which are mainly affected by local economic development levels, tax policies, market competition and other factors.

Domestic Price Expectation

Since Rilugoli is not currently available in the country, its domestic price is not yet clear. However, with the development of the domestic pharmaceutical industry and the intensification of market competition, the price of Rilugoli may fluctuate due to various factors after it is launched in the country in the future. Patients can pay attention to relevant medical information and learn about price trends in a timely manner.

When choosing a purchase channel, patients should comprehensively consider factors such as drug quality, price, and service, and choose the purchase method that best suits them.